- Home
- Publications
- Publication Search
- Publication Details
Title
Statins and Their Effect on PCSK9—Impact and Clinical Relevance
Authors
Keywords
Statin myalgia, Myopathy, Creatine kinase
Journal
Current Atherosclerosis Reports
Volume 18, Issue 8, Pages -
Publisher
Springer Nature
Online
2016-06-17
DOI
10.1007/s11883-016-0604-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
- (2016) Jin M. Cheng et al. ATHEROSCLEROSIS
- Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk FactorsCLINICAL PERSPECTIVE
- (2016) Karin Leander et al. CIRCULATION
- The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy
- (2016) Q Feng et al. PHARMACOGENOMICS JOURNAL
- Effects of Niacin, Statin, and Fenofibrate on Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels in Patients With Dyslipidemia
- (2015) Amit V. Khera et al. AMERICAN JOURNAL OF CARDIOLOGY
- Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
- (2015) Xin-Lin Zhang et al. BMC Medicine
- Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials
- (2015) A. Sahebkar et al. DIABETES OBESITY & METABOLISM
- The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis
- (2015) Michael J. Lipinski et al. EUROPEAN HEART JOURNAL
- The Relationship between the Plasma PCSK9 Levels and Platelet Indices in Patients with Stable Coronary Artery Disease
- (2015) Sha Li et al. Journal of Atherosclerosis and Thrombosis
- The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis
- (2015) Gaojun Cai et al. Lipids in Health and Disease
- Association between trajectories of statin adherence and subsequent cardiovascular events
- (2015) Jessica M. Franklin et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Circulating Levels of Proprotein Convertase Subtilisin Kexin Type 9 are Elevated by Fibrate Therapy
- (2014) Amirhossein Sahebkar Cardiology in Review
- PCSK9 gene mutations and low-density lipoprotein cholesterol
- (2014) Na-Qiong Wu et al. CLINICA CHIMICA ACTA
- Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
- (2014) S. Matthijs Boekholdt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Resistance and intolerance to statins
- (2014) Ž. Reiner NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
- (2014) Iris Postmus et al. Nature Communications
- Comparison of Effects of Pitavastatin Versus Pravastatin on Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels in Statin-Naive Patients With Coronary Artery Disease
- (2013) Tsuyoshi Nozue et al. AMERICAN JOURNAL OF CARDIOLOGY
- Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education
- (2013) Melissa Y. Wei et al. Journal of Clinical Lipidology
- Evidence from a Randomized Trial That Simvastatin, but Not Ezetimibe, Upregulates Circulating PCSK9 Levels
- (2013) Heiner K. Berthold et al. PLoS One
- Effect of Statins on Skeletal Muscle Function
- (2012) Beth A. Parker et al. CIRCULATION
- Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
- (2012) Daniel I. Chasman et al. Circulation-Cardiovascular Genetics
- Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
- (2012) David Sullivan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations
- (2011) Donald G. Pittman et al. AMERICAN JOURNAL OF CARDIOLOGY
- Plasma PCSK9 is increased by Fenofibrate and Atorvastatin in a non-additive fashion in diabetic patients
- (2010) P. Costet et al. ATHEROSCLEROSIS
- Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
- (2009) John F. Thompson et al. Circulation-Cardiovascular Genetics
- A new method for measurement of total plasma PCSK9: clinical applications
- (2009) Geneviève Dubuc et al. JOURNAL OF LIPID RESEARCH
- Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population
- (2008) Eliana Polisecki et al. ATHEROSCLEROSIS
- Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response
- (2008) Deepak Voora et al. Circulation-Cardiovascular Genetics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started